Dolby Laboratories, Inc. DLB Increase (Decrease) in Contract with Customer, Asset

Increase (Decrease) in Contract with Customer, Asset at other companies

T-Mobile USTMUS

$61M-23.8%

Rocket Lab USA, Inc.RKLB

$13.43M+721%

Northrop GrummanNOC

$551M-48.5%

Bloom EnergyBE

$64.69M+4,292%

Ionis PharmaceuticalsIONS

$7.63M+115%

GE HealthCare TechnologiesGEHC

$46M+188%

Other financials

Income statement

See full

Revenue$395.6M+7.1%

Gross profit$350.9M+5.1%

Operating income$112.9M+4.8%

Net income$94.9M+3.4%

EPS (diluted)$0.99+5.3%

Balance sheet

See full

Cash & equivalents$673.8M-10.2%

Total debt$49.7M+22.9%

Total equity$2.6B+1.7%

Total assets$3.2B+0.6%

Cash flow

See full

Operating cash flow$92.5M-47.1%

CapEx$9.1M+31.4%

Free cash flow$83.4M-50.3%

Valuation

See full

Market cap$4.95B-25.9%

Profitability

See full

Gross margin87.4%-1.5pp

Operating margin18.5%-2.0pp

Net margin17.9%-1.6pp

FCF margin22.1%-7.5pp

Returns & leverage

See full

Return on equity9.4%-0.9pp

Debt / equity0×0.0×

Current ratio3×-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerAsset.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s increase (decrease) in contract with customer, asset.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s increase (decrease) in contract with customer, asset?: Dolby Laboratories, Inc. (DLB) reported increase (decrease) in contract with customer, asset of $40.65M in Q1 2026.
How has Dolby Laboratories, Inc.'s increase (decrease) in contract with customer, asset changed year-over-year?: Dolby Laboratories, Inc.'s increase (decrease) in contract with customer, asset increased by 330.2% year-over-year, from $9.45M to $40.65M.